LCZ696D_ENTRESTO_CARDIOVASCULAR: payments to doctors
Payments that named LCZ696D_ENTRESTO_CARDIOVASCULAR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $110K
- Providers
- 21
- Transactions
- 90
- Average per transaction
- $1,223
The per-transaction average — $1,223 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 21 providers the average total is $5,241, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis Pharma AG | $110,063 | 100.0% |